Mechanisms of Alcohol Withdrawal
戒酒机制
基本信息
- 批准号:10443839
- 负责人:
- 金额:$ 42.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-10 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsAddressAlcohol withdrawal syndromeAlcoholsAnimal ModelApicalBehaviorBehavioralBenzodiazepinesBrainChronicClinicalComplexCoupledDangerousnessDataDendritesDependenceDevelopmentDiagnosisDoseDrug Metabolic DetoxicationDrug TargetingEpilepsyEthanolFRAP1 geneGrantHippocampus (Brain)In VitroIncidenceIon Channel ProteinKnock-outKnowledgeLeadLongevityMediatingMembraneMessenger RNAMidline Thalamic NucleiMissionModelingMolecularMouse StrainsNatureNeuronsOrganismOutcomePathway interactionsPatternPharmaceutical PreparationsPharmacologyPopulationPotassium ChannelPredispositionPreparationPreventionProceduresPropertyProtein Synthesis InhibitorsProteinsPublic HealthPyramidal CellsResearchSeizuresSignal TransductionSirolimusStructureSubstance Withdrawal SyndromeSubstance abuse problemSymptomsSynapsesT-Type Calcium ChannelsTestingThalamic structureTimeToxic effectTranslationsUnited States National Institutes of HealthUp-RegulationWithdrawalWithdrawal SymptomWorkaddiction liabilityalcohol abuse therapyalcohol effectalcohol exposurealcohol related problemalcohol use disorderdrinkingexperienceexperimental studygain of functionimprovedin vivonervous system disordernetwork modelsneural circuitneuronal cell bodynoveloptogeneticspreventresponsesuccesstransmission processvoltagevoltage clamp
项目摘要
PROJECT SUMMARY
Alcohol withdrawal (WD) produces a range of dangerous clinical symptoms, including intense seizures.
Hyperexcitability underlying seizures is produced by an array of intrinsic membrane properties that are
disrupted by ethanol (EtOH). Prior work has demonstrated that chronic EtOH exposure and WD produce an
up-regulation of ion channel proteins and a gain of function that promotes WD seizure. A remaining gap in
our understanding of WD-related seizure is a testable model that places cellular changes in a network
context. WD produces upregulation and increased bursting in midline thalamic nuclei. In hippocampus,
mammalian target of rapamycin Complex 1 (mTORC1) is activated in CA1 neurons during WD, represses
translation of Kv1.1, and results in reduced inhibition that we hypothesize will allow invasion of thalamic
bursts and increased epileptiform population discharges. We have developed a new model of network
excitability that will allow us to study the emergence, time course and molecular underpinnings of EtOH WD
hyperexcitability and seizure. We will address the following aims: In Aim 1, we will determine the intrinsic
properties contributing to membrane hyperexcitability in midline thalamus and CA1 due to ethanol WD
seizure. Using voltage clamp recordings in an in vitro preparation coupled with pharmacological approaches,
we will determine whether epileptiform discharges in WD are ultimately dependent on a progressive
imbalance between excitatory burst discharges in thalamus (which depend on PKC), and reduced K+ currents
in CA1 pyramidal cells (which are controlled by mTOR). In Aim 2, we will Determine important regulators of
dendritic excitability in thalamus and CA1 in EtOH WD seizure. mTOR signaling is implicated in the
development of spontaneous seizures in epilepsy, and we show data that it is active during WD. Using
molecular approaches, we will toggle mTOR activity in the presence and absence of protein synthesis
inhibitors. We will test whether mTORC represses translation of Kv1.1, as suggested by our preliminary data.
In Aim 3, we bring together the cellular and molecular findings to determine the effects of WD-mediated
changes to network excitability and seizure susceptibility in vivo. Using a novel optogenetic approach, we will
test whether stimulation of the thalamo-HC pathway during WD will elicit enhanced epileptiform activity
compared to controls that will depend on patterned activity at facilitated CA1 synapses. We expect that
disruptions of mTORC1 will modify or reverse WD-mediated excitability. Seizure threshold is significantly
reduced during repeated EtOH WD and we will use this fact to test the hypothesis that drugs effective against
WD-induced hyper-excitability will also be effective at raising seizure thresholds to baseline levels. Success in
these experiments will provide a more comprehensive understanding of how brief spindle episodes and spike
wave complexes promote or support tonic-clonic WD seizures – which could lead to the identification of novel
pathways and associated drug targets that will provide a means to prevent WD seizure, and to more effectively
treat it.
项目摘要
酒精戒断(WD)会产生一系列危险的临床症状,包括强烈的癫痫发作。
癫痫发作背后的过度兴奋是由一系列内在膜特性产生的,
用乙醇(EtOH)破坏。先前的工作已经证明,慢性乙醇暴露和WD产生
离子通道蛋白的上调和促进WD发作的功能的获得。一个剩余的差距,
我们对WD相关癫痫发作的理解是一个可测试的模型,
上下文WD在中线丘脑核中产生上调和增加的爆发。在海马体中,
哺乳动物雷帕霉素靶蛋白复合物1(mTORC 1)在WD期间在CA 1神经元中被激活,抑制
Kv1.1的翻译,并导致抑制减少,我们假设这将允许丘脑的侵袭。
爆发和癫痫样群体放电增加。我们开发了一种新的网络模型
兴奋性,这将使我们能够研究的出现,时间进程和分子基础的EtOH WD
过度兴奋和癫痫发作。我们将实现以下目标:在目标1中,我们将确定内在的
由于乙醇WD,导致中线丘脑和CA 1中膜过度兴奋的性质
癫痫。在体外制备中使用电压钳记录结合药理学方法,
我们将确定WD的癫痫样放电是否最终依赖于进行性的
丘脑兴奋性爆发性放电(依赖于PKC)与K+电流减少之间的不平衡
在CA 1锥体细胞(由mTOR控制)中。在目标2中,我们将确定重要的监管机构,
EtOH WD发作时丘脑和CA 1区树突兴奋性。mTOR信号转导与
发展的自发性癫痫发作,我们显示的数据,它是活跃的WD。使用
分子方法,我们将在蛋白质合成存在和不存在的情况下切换mTOR活性
抑制剂的我们将测试mTORC是否抑制Kv1.1的翻译,正如我们的初步数据所建议的那样。
在目标3中,我们将细胞和分子研究结果结合起来,以确定WD介导的
体内网络兴奋性和癫痫易感性的变化。使用一种新的光遗传学方法,我们将
测试在WD期间刺激丘脑-HC通路是否会引起增强的癫痫样活动
与依赖于易化CA 1突触的模式化活动的对照相比。我们预计
mTORC 1的破坏将改变或逆转WD介导的兴奋性。癫痫发作阈值显著高于
在重复EtOH WD期间减少,我们将利用这一事实来检验药物有效对抗
WD诱导的过度兴奋也将有效地将癫痫发作阈值提高到基线水平。成功
这些实验将提供一个更全面的理解,如何短暂的纺锤体事件和穗
波复合物促进或支持强直-阵挛性WD发作-这可能导致新的
途径和相关的药物靶点,这将提供一种预防WD发作的方法,
治疗它。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DWAYNE W GODWIN其他文献
DWAYNE W GODWIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DWAYNE W GODWIN', 18)}}的其他基金
Evaluating Gene Therapy Strategies to Treat Epilepsy Using a Novel Optogenetic Measure of Network Excitability and Seizure Susceptibility
使用网络兴奋性和癫痫易感性的新型光遗传学测量方法评估治疗癫痫的基因治疗策略
- 批准号:
10215636 - 财政年份:2020
- 资助金额:
$ 42.98万 - 项目类别:
Evaluating Gene Therapy Strategies to Treat Epilepsy Using a Novel Optogenetic Measure of Network Excitability and Seizure Susceptibility
使用网络兴奋性和癫痫易感性的新型光遗传学测量方法评估治疗癫痫的基因治疗策略
- 批准号:
10057595 - 财政年份:2020
- 资助金额:
$ 42.98万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42.98万 - 项目类别:
Research Grant